Hormonal
Short sleep duration (e.g., 5 hours vs 8 hours) causes hormonal shifts (lower leptin, higher ghrelin) and elevated cortisol that increase appetite and abdominal fat deposition, thereby promoting obesity.
Prioritize getting 7-9 hours of sleep. Short sleep duration directly alters hunger hormones (lowering satiety signals like leptin and raising hunger signals like ghrelin) and increases cortisol, which drives cravings for high-fat, high-sugar foods and abdominal fat storage. Fixing sleep is a primary lever for weight management.
Taheri et al found that shorter sleep durations (5 hours per night versus 8 hours per night) were associated with 15.5% lower leptin levels and 14.9% higher ghrelin levels... Additionally, Dallman et al have proposed that chronic elevation of glucocorticoids, such as cortisol... may play a role in increasing a person’s desire to consume high fat and high sugar foods, as well as their propensity to store fat in the abdominal region.
Why this rating
Supported by multiple cohort studies (Wisconsin Sleep Cohort) and mechanistic proposals, though causality in observational data is noted as difficult to ascertain.
Source
Association between sleep disorders, obesity, and exercise: a review
Trent A. Hargens et al. · Nature and Science of Sleep · 2013
DOI 10.2147/nss.s34838
More from this paper
- Regular moderate-intensity aerobic exercise improves sleep quality, reduces sleep onset latency, and decreases OSA severity, independent of significant weight loss.Good
- Obstructive Sleep Apnea (OSA) contributes to obesity through mechanisms including increased preference for calorie-dense foods, altered hormonal regulation (leptin resistance), and decreased physical activity due to daytime sleepiness.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →